Navigate the AI era with confidence. TCS helps you turn AI into a strategic partner that empowers talent, reimagines processes, and accelerates business transformation.
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
Matthew Moyer, Director of Operations and Supply Tech, Merck, and Narayanan R., Chief Architect, TCS ADD Platform discuss and demonstrate approaches and real-life examples to enable patient-centric trials through a unified, integrated platform.
Clinical trials have been primarily driven by a site-centric approach i.e., face-to-face interactions at the site. With COVID-19 severely impacting the functioning of traditional clinical trials, it has opened a world of opportunities and possibilities to move to the next generation of clinical trials augmented by digital technologies with patient at its center.
TCS partnered with Merck to realize the latter’s vision on a digitally enabled trials platform (DETP), leveraging the Decentralized Trials solution from TCS ADD offering. The DETP was aimed at resolving challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy and calculating RoI. The partnership facilitated a host of features being actively tested, viz-a-viz, electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer and BYOD.